fremanezumab has completed phase iii trials and is under review by the fda to prevent migraine and
.
.
.". plemmons added, "particularly in a time when mental health resources for children appear to be static, and woefully scarce across the u.s".
.
.
recommended
.
"i can't think of anything else where we have done that medically," van den veyver said.
.
.
.